Beranda › Leukemia › California

Uji klinis Leukemia di California

28 studi untuk Leukemia mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 1, Duarte
Quetzal Site 7, Los Angeles
Quetzal Site 5, Stanford

Menerima pesertaFase 3

Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07504458

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

USC Norris Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06824168

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

City of Hope Comprehensive Cancer Center, Duarte
UCLA Medical Center, Los Angeles
Stanford Cancer Institute, Stanford

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04996875

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Research Site, La Jolla

Menerima pesertaFase 3

Usia 18 hingga 18 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07509151

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

Stanford University, Palo Alto

Menerima pesertaFase 1

Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06408194

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Children s Hospital of Los Angeles, Los Angeles

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 5 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT05237986

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Lucille Packard Children's Hospital of Stanford University, Palo Alto

Menerima pesertaFase 1

18 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07573111

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

USC Norris Comprehensive Cancer Center, Los Angeles
UCLA Health - Bowyer Oncology Center, Los Angeles
UC Irvine Health Chao Family Comprehensive Cancer Center, Orange
dan 1 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

University of California, Fresno, Clovis
University of California, San Diego, La Jolla
Cedars-Sinai Medical Center, Los Angeles
dan 2 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07007312

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

Menerima pesertaFase 2

Usia 7 hingga 25 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05082519

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Duarte
Research Site, Los Angeles
Research Site, Palo Alto

Menerima pesertaFase 1/2

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT06137118

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Stanford University, Palo Alto

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06340737

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

City of Hope, Duarte
Valkyrie Clinical Trials, Los Angeles

Menerima pesertaFase 1/2

Usia 13 hingga 90 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06533579

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT06810778

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06580002

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

UCLA Department of Medicine, Los Angeles

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07216443

A Study of Revumenib and Mezigdomide in People With Leukemia

City of Hope Cancer Center (Data collection only), Duarte

Menerima pesertaFase 1/2

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT07356154

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Dren Investigational Site, Duarte
Dren Investigational Site, Irvine
Dren Investigational Site, Redwood City

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

City of Hope Comprehensive Cancer Center, Duarte
Kaiser Permanente-Oakland, Oakland
Lucile Packard Children's Hospital Stanford University, Palo Alto
dan 1 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT01790152

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Keck School of Medicine of USC, Los Angeles
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

Menerima pesertaFase 2/3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT04256317

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

City of Hope, Duarte
Los Angeles Cancer Network, Los Angeles
UCLA Medical Center of Hematology/Oncology, Los Angeles
dan 1 lainnya

Menerima pesertaFase 1/2

Usia 12 hingga 95 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT04329728

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Moores UC San Diego Cancer Center, La Jolla
USC / Norris Comprehensive Cancer Center, Los Angeles
UCLA - Bowyer Oncology Center, Los Angeles
dan 1 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT05735184

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

City of Hope, Duarte

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT05366881

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

City of Hope - Duarte, Duarte

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Okt 2025 · NCT06549790

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
dan 3 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

San Francisco VA Medical Center, San Francisco, CA, San Francisco

Menerima pesertaFase 2

Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 14 Okt 2025 · NCT06520098

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

City of Hope Medical Center, Duarte
University of California Los Angeles, Los Angeles
Stanford Cancer Center, Palo Alto

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2025 · NCT06501196

Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.

Children's Hospital Los Angeles, Los Angeles

Menerima pesertaSukarelawan sehat diterima

Usia 3 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2025 · NCT06360718

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.